# Hanyang University Seoul Hospital

Organization · id `cardio:org-hanyang-university-seoul-hospital` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ROR record 04n76mm80](<https://ror.org/04n76mm80>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 6 trials in this atlas.

## Technical summary

Sponsor class other. Matched to ROR record 04n76mm80 by an exact name.

## The registry's words

- Sponsor name: Hanyang University Seoul Hospital
- Sponsor class: OTHER
- ROR name: Hanyang University Seoul Hospital

## Connected pages

- Sponsors: A Randomized, Double-Blind, Placebo-Controlled, 3x3 Factorial Design, Phase II Study to Evaluate the Antihypertensive Efficacy and Safety of Combination of Fimasartan and Amlodipine in Patients With Essential Hypertension (`cardio:ct-nct01518998`)
- Sponsors: Fimasartan/Amlodipine Combination Phase III (`cardio:ct-nct02152306`)
- Sponsors: A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease (`cardio:ct-nct05427786`)
- Sponsors: HOST - DAPT Duration According the Bleeding Risk (`cardio:ct-nct05631769`)
- Sponsors: Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study (`cardio:ct-nct07084259`)
- Sponsors: TRADENT Scoring Balloon Versus Non-scoring Balloon for Lesion Preparation in DCB-Based Coronary Intervention (`cardio:ct-nct07899021`)

## Provenance

Content hash: b31bd1016e1bc350e1f78f9e36de0e1c4964a3559ca158267f6fce6c97895934
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
